Home » Newsletters » BioWorld Science

BioWorld Science

April 19, 2007

View Archived Issues

Preclinical and clinical data on novel inhibitors of HCV NS5B polymerase and NS3 proteases

Clinical studies of bifeprunox presented

Snapshots of drugs being evaluated for schizophrenia

Recent patents impart new treatments for cardiovascular disorders

New treatment options for inflammatory disorders reported in recent patents

In vitro and in vivo characterization of an orally active VEGF/PDGF inhibitor

New therapeutic agents for cancer covered in recent patent literature

AZD-7762, a potent and selective Chk kinase inhibitor, potentiates activity of DNA-damaging agents

Novel Met inhibitor from Pfizer with potential in osteosarcoma

First-in-class non-ATP-selective Src inhibitor designed by Kinex

Phase I results in cancer patients reported for CDK inhibitor P-276-00

FDA grants orphan drug status to ganciclovir for acute herpetic keratitis

Clearance for phase I Japanese study of nimotuzumab for solid tumors

Inecalcitol shows high level of tolerance in phase I trial

SPRC-AB01 granted fast track status for chronic sinusitis

KD-7040 begins second phase I study for neuropathic pain

Phase III confirmatory study of DX-88 for HAE begins treatment

New Zealand regulator approves phase I/IIa study of DiabeCell

Indevus and Valera complete merger

Alnylam to advance ALN-VSP01 for liver cancer

FDA licenses first U.S. avian influenza vaccine for humans

Polyphenon E Ointment accepted for review in Germany, Austria, and Spain

Neupro studied for sleep problems, early morning motor symptoms in Parkinson's

Prevascar improves scar appearance following incisional wounds

Biliary fibrosis aggravated by the antiangiogenic alpha(v)beta(3) antagonist cilengitide in rats

Arixtra approved in Japan

Japanese approval for Alvesco

Uritos approved for overactive bladder in Japan

Valtrex approved in Japan for pediatric varicella

Zetia approved in Japan

Popular Stories

Today's news in brief
BioWorld
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
Keros reports beneficial effects of RKER-065 in ALS model
BioWorld Science
Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 17, 2026